Mousa Bateh
Primary Podiatric Medicine · Jacksonville, FLNPI 1184623555
Payments from drug & device makers
What this record shows
24 manufacturers reported payments, led by Tosoh Bioscience, Inc. at 41.1% of the total. Reporting peaked in 2019 at $2,076 and has fallen 92.5% since, to $156 in 2025.
Across 105 payments — averaging $36.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tosoh Bioscience, Inc.$2K
- Organogenesis Inc.$404
- Abbott$349
- Mannkind Corporation$349
- Novo Nordisk$202
- Orthofix Medical, Inc.$155
- plus $786 from 18 others
What the payments were for
- Food & beverage$2,24659%
- Gifts$1,56641%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tosoh Bioscience, Inc. | 2 | $1,566 |
| Organogenesis Inc. | 16 | $404 |
| Abbott | 13 | $349 |
| Mannkind Corporation | 5 | $349 |
| Novo Nordisk | 25 | $202 |
| Orthofix Medical, Inc. | 1 | $155 |
| Medtronic | 8 | $147 |
| Xeris Pharmaceuticals, Inc. | 4 | $68 |
| IBSA Pharma Inc. | 3 | $65 |
| AstraZeneca | 3 | $59 |
| Lilly USA, LLC | 3 | $59 |
| Smith+Nephew | 3 | $58 |
| Corcept Therapeutics | 3 | $56 |
| Amgen | 3 | $53 |
| Lifescan, Inc. | 2 | $32 |
| Endo Pharmaceuticals Inc. | 2 | $28 |
| Radius Health, Inc. | 1 | $27 |
| Johnson & Johnson | 2 | $24 |
| Recordati_rare_diseases_inc. | 1 | $23 |
| EUSA Pharma (US) LLC | 1 | $23 |
| Dexcom, Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Tandem Diabetes Care, Inc. | 1 | $14 |
| Nevro Corp. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,812 in reported general payments places this provider in the 85th percentile of 68 primary podiatric medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 95 | $703 |
| Ciprofloxacin Hcl | 26 | $207 |
| Colchicine | 12 | $70 |
| Methylprednisolone | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Jacksonville
- Andrew BartellJacksonville$87
- Emmanuel LagoutarisJacksonville$73
- Robert SnyderTamarac$623K
- Melissa VerdeLongwood$257K
- Kevin LapoffGreenacres$64K
- Beth PearceSt Augustine$27K
- Dmitry SandlerHialeah$11K
- Richard MercadoMiami$10K
- Gladys de LeonOrlando$8K
- Tanika HarlisPort Saint Lucie$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.